Celgene CorpAdd to My Watchlist

CELG:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 118.23
    Last
  • 1.23  -1.03%
    Today's Change
  • 119.46
    Previous Close
  • Today
     
    94.39
    127.00
    52 Week Low - High
8:10 pm ET 2/24/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding778 million
Market Cap$92 billion
Return on Equity ttm31.94%
Last DividendCELG:US does not pay a dividend
Earnings
EPS: Year Actual ttm4.010
EPS: Year Est. 12/17 ttm7.096
 
EPS: Quarterly Actual 12/16 1.61
EPS: Quarterly Est. 3/17 1.63
 
Price/Earnings ttm29.48
Relative Price/Earnings1.353
Earnings Growth Rate27.23
Company Description
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
Revenue$11 billion
Net Income$2 billion
Total Assets$28 billion
Employees7,132
Web Sitewww.celgene.com

Latest Headlines

Watchlist

Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now

 

Not Registered?

Get complete access to The Washington Post online - it's FREE!